Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.
Sobha SivaprasadFaruque D GhanchiSimon P KellyAjay KotagiriJames TalksPeter Henry ScanlonHellen McGoeyAndrew NolanMoneeb SaddiqJackie NapierPeter Morgan-WarrenPublished in: Eye (London, England) (2023)
Results indicate that upon DMO diagnosis, patients were treated promptly, and most visits were combined (treatment and assessment) or monitoring only. Most IVT-AFL was administered by non-physicians with a similar treatment-related safety profile as IVT-AFL administered by physicians.
Keyphrases
- primary care
- healthcare
- end stage renal disease
- type diabetes
- newly diagnosed
- ejection fraction
- chronic kidney disease
- diabetic retinopathy
- optical coherence tomography
- peritoneal dialysis
- skeletal muscle
- prognostic factors
- vascular endothelial growth factor
- weight loss
- endothelial cells
- patient reported outcomes
- cataract surgery
- clinical evaluation